Category: Orthopedics
![Royal Biologics Launches Amnio-Maxx™, an Extracellular Matrix Product Derived From Human Amniotic Placental Tissue](https://cdn.nwe.io/files/x/a8/89/0b861c83c2b4146bd3a14b4d7c7e.jpg)
FEATURED
50% Commission Offering for Initial Distributors. Amnio-Maxx™ will be used to treat various conditions in orthopedics and sports medicine.
Royal Biologics' Cryo-Cord™, Amnio-Maxx™, Amnio-Maxx™ Lite and Derm-Maxx™ Receive High-Tier Reimbursement in the Hospital Outpatient Departments and Reimbursement in the Physician Office to Treat Chronic Non-Healing Wounds
![Royal Biologics Announces the Launch of Fibri-Cell™, Live Cellular Cortical Fibers With Osteo-Spin™ Technology](https://cdn.nwe.io/files/x/ea/e6/efebc63ae75c46b53c6d3180f620.jpg)